It can be incredibly frustrating being constantly told that you have a drinking problem when you've never had a drop but for this 61-year-old Pennsylvania woman, each and every effort to become eligible for a life-saving liver transplant was thwarted by an insurmountable hurdle—she kept testing positive for alcohol. No matter how many times she asserted that she had not been drinking, her urine drug screens read otherwise. Accordingly, she was refused entry on the liver transplant waiting list numerous times, the doctors presuming she was struggling with alcohol addiction.

But the reality was much stranger than anyone might have dreamed. In what seems to be a first in medical history, physicians found that her own bladder was secreting alcohol—a process so unusual that it had not been given an official name yet. Her case sheds new light on how the human body, under abnormal circumstances, can simulate effects of alcohol use without ingestion.

The patient had severe liver cirrhosis, a scarring and liver function loss that requires a transplant to save her life. She also had diabetes that was uncontrolled, leading to high levels of glucose (sugar) in her urine.

Initially, physicians at one hospital brushed off her assertion that she was sober, believing that she was denying alcohol addiction. When she subsequently reported for assistance at the University of Pittsburgh Medical Center (UPMC) Presbyterian Hospital, the same problem persisted. Her urine samples consistently registered the presence of ethanol, the beverage type of alcohol, further increasing the medical staff's suspicion. Yet there was a critical discrepancy: whereas her urine tested positive for ethanol, it was free of the usual metabolic byproducts—ethyl glucuronide and ethyl sulfate—seen days after drinking.

This contradiction interested Dr. Kenichi Tamama, a senior researcher on the study and an associate professor of pathology and medical director of UPMC's Clinical Toxicology Laboratory. If the woman was consuming alcohol, the metabolites should have been found in her urine. Also, her blood alcohol tests were negative, and she never showed any symptoms of being intoxicated.

Following more research, the doctors discovered a surprising cause: yeast in the woman's bladder was fermenting sugar into alcohol. The process, normally related to making beer or wine, was occurring within her body. Consequently, they suggested calling her condition "urinary auto-brewery syndrome" or "bladder fermentation syndrome."

This condition is similar to, but different from, a rare disorder called auto-brewery syndrome (ABS), also referred to as gut fermentation syndrome. ABS happens when some microbes in the gut ferment carbohydrates into alcohol, leading to people with the condition becoming intoxicated without consuming alcohol. In the case of the Pennsylvania woman, however, her condition was confined to her bladder, so the alcohol did not reach her bloodstream. She therefore never seemed drunk, although her urine was ethanol-positive.

To be sure about their suspicion, scientists performed an experiment. The researchers took a fresh urine specimen from the patient and incubated it at a temperature of the human body (98.6°F or 37°C). Ethanol in the sample zoomed within no time. The sample did not yield any alcohol, however, if it were incubated below normal temperature (39°F or 4°C) or after the addition of a chemical for stopping fermentation. This test conclusively established that the yeast in her bladder was the cause of the alcohol production.

Additional lab tests determined the offender—Candida glabrata, a yeast that is normally present in the human microbiome. Candida glabrata is closely related to brewer's yeast, which is employed in alcoholic fermentation. Under conditions of excess sugar, as in the case of the woman with uncontrolled diabetes, Candida glabrata metabolized the glucose in her bladder to ethanol.

Due to these observations, the woman was finally reevaluated for liver transplant, a move that could turn around her condition and save her life. Her case highlights the need to cast aside standard assumptions of diagnosis and to explore infrequent metabolic phenomena.

Although sporadic reports of such cases have appeared, they were usually considered postmortem changes or laboratory artifacts due to the improper storage of urine samples. This case presents tangible evidence that bladder fermentation is possible in living patients and serves to increase awareness among medical professionals regarding distinguishing between true alcohol intake and endogenously produced alcohol.

What Is Auto-Brewery Syndrome?

Auto-brewery syndrome, or gut fermentation syndrome, is a rare condition where carbohydrates ferment to alcohol within the gastrointestinal tract. Patients can present with signs of intoxication, such as dizziness, slurred speech, and coordination impairment, without alcohol consumption. This results from an imbalance in gut microbiota, typically yeasts such as Candida.

The syndrome is well-documented in medical literature for more than 50 years, yet it remains significantly underdiagnosed. A study published in 2021 estimated that fewer than 100 cases had been reported globally. Experts, however, estimate that numerous other people might be suffering from the condition unknowingly, as the symptoms might be confused with alcohol intake, metabolic conditions, or psychiatric issues. In severe instances, people with ABS have been charged with DUI, even though they consumed no alcohol.

How Is Urinary Auto-Brewery Syndrome Different From Typical Auto-Brewery Syndrome?

Urinary auto-brewery syndrome (bladder fermentation syndrome) and conventional auto-brewery syndrome (gut fermentation syndrome) are similar but differ significantly.

In urinary auto-brewery syndrome, alcohol is synthesized in the bladder because of microbial fermentation of sugar. It may also happen in an open sample of urine outside the refrigerator. But as the alcohol is contained within the bladder and does not get into the bloodstream, individuals who have it do not have symptoms of being intoxicated.

In contrast, classical auto-brewery syndrome happens within the gastrointestinal tract, where fermentative microbes metabolize carbohydrates into alcohol. This alcohol is absorbed into the bloodstream, resulting in a positive plasma ethanol reading and creating symptoms of intoxication similar to that following alcohol intake.

Netflix and adult film star Kylie Page's sudden death just at the age of 28 has come has a shock for the entertainment industry and her family. She was found dead at her apartment on June 25 after a friend called the cops when the friend was unable to reach her.

By the time the fire department arrived at her Hollywood residence, she had already been pronounced dead.

Kylie Page Death Reason

According to US Weekly's report the evidence suspect a drug overdose case as the police confirmed for finding fentanyl and drug paraphernalia. According to publicly available records from the Los Angeles County Medical Examiner, her cause of death is currently listed as “deferred,” indicating further investigation is underway, possibly involving suspected foul play. Her death was confirmed by the Canadian adult entertainment company she worked for.

Also Read: Kate Middleton Opens Up About Her 'Really Difficult' Time During Chemotherapy And How Nature Helped Her Heal

"The Brazzers team is deeply saddened to learn of Kylie Page’s passing,” the company said in a statement on X. “Kylie will be remembered for her laughter, kindness, and bringing light wherever she went. We extend our heartfelt condolences to Kylie’s family, friends, and fans during this difficult time.”

Fentanyl & Paraphernalia overdose: How These Drugs Impact Your Body?

Page's death has again reminded people of drug use and abuse in the entertainment industry cases like Matthew Perry's death and Liam Payne's death.

In case of Page, fentanyl and drug paraphernalia was found in her home.

As per the Edge Treatment Center that is licensed by the California State Department of Health Care Services, and US federal law, drug paraphernalia is any device, item, or component of any type which is mainly meant or crafted for the purpose of production, compounding, transforming, obscuring, generating, processing, prepping, injecting, inhaling, consuming, or otherwise including a banned drug into our bodies.

Common Drugs Linked with Paraphernalia

• Marijuana/cannabis
• Cocaine
• Heroin and other opioids
• Methamphetamines
• Ecstasy
• Inhalants

What Is Fentanyl and Why Is It So Dangerous?

As per the United States Drug Enforcement Administration (DEA), fentanyl is a potent synthetic opioid drug approved by the Food and Drug Administration for use as an analgesic (pain relief) and anesthetic. It is approximately 100 times more potent than morphine and 50 times more potent than heroin as an analgesic.

It is also known as Apace, China Girl, China Town, Dance Fever, and by other various names. It can be consumed through snorting, sniffing, smoking, or orally by pill or tablet. It could also be spiked onto blotter paper, patches or sold alone or in combination with heroin and other substances.

How Fentanyl Affects the Body and Mind

As per the National Institute on Drug Abuse, US, Fentanyl and other illegally produced synthetic opioids have played a major role in the overdose crisis in the United States since 2013.

Since about 2017, overdose deaths often involve use of multiple drugs. In many cases, fentanyl is one of these drugs. When fentanyl is mixed with other drugs, either on purpose or unknowingly, the combination can have more serious health effects.

Like other opioid pain relievers, fentanyl can cause a range of effects including relaxation, euphoria, pain relief, sedation, confusion, drowsiness, dizziness, nausea, vomiting, urinary retention, constricted pupils, and slowed breathing.

In cases of overdose, symptoms may include stupor, altered pupil size, cold and clammy skin, bluish discoloration (cyanosis), coma, and respiratory failure, which can be fatal. A combination of coma, pinpoint pupils, and respiratory depression is a strong indicator of opioid intoxication.

The U.S. Food and Drug Administration (FDA) has announced a significant update to the labeling of all extended-release medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD). The change specifically targets the use of these drugs in children younger than six, warning about the risk of weight loss and other adverse reactions.

What Is ADHD?

ADHD is a common neurodevelopmental disorder that typically begins in childhood. It is characterized by symptoms such as inattention, hyperactivity, and impulsivity that can interfere with a child's development and daily functioning. Treatment usually involves a combination of behavioral therapy and medication, including stimulants like amphetamines and methylphenidate.

Labeling Change Reflects Off-Label Prescribing Trend

Although extended-release stimulants are not approved for use in children under six, the FDA notes that healthcare professionals sometimes prescribe them “off-label” to younger patients. This is typically done in cases where other treatments have failed or when symptoms are especially severe. However, the FDA warns that clinical trials have shown young children process these drugs differently from older children, often resulting in higher concentrations of the medication in the body.

These higher drug levels have been associated with an increased likelihood of side effects, including clinically significant weight loss. As a result, the FDA is requiring drug manufacturers to include a new “Limitation of Use” section in the prescribing information for all extended-release stimulant medications.

This section will outline the risks specific to children under six, including:

• Higher plasma concentrations of the drug
• Greater rates of side effects, including reduced appetite and weight loss
• The fact that extended-release formulations are not approved for this age group

Monitoring and Alternative Options Recommended

For young children already taking extended-release ADHD stimulants, the FDA advises healthcare providers to closely monitor the patient’s growth and development. Pediatricians should regularly chart weight and height to detect early signs of weight loss. If weight loss becomes a concern, alternative treatments should be considered.

These may include:

• Switching to immediate-release stimulants, which may be easier to manage in younger children
• Exploring non-medication interventions, such as behavioral therapies and parent training programs
• Reevaluating the overall treatment plan to ensure it aligns with the child’s developmental needs and physical health

What Should Parents and Caregivers Do?

Parents and caregivers are encouraged to stay alert for signs of weight loss in children taking extended-release stimulants. If any concerning changes in appetite or weight are noticed, it’s essential to consult the child’s pediatrician. The doctor can then weigh the benefits and potential harms of continuing the current medication and discuss safer alternatives if needed.

The FDA's move comes as part of its ongoing effort to improve pediatric medication safety and ensure that drug use in children is backed by evidence, especially when used outside of official guidelines.

Kate Middleton or Catherine, Princess of Wales reflected on the aftermath of chemotherapy in her first public appearance since she had unexpectedly withdrawn from Royal Ascot just two weeks ago.

She has called the entire experience "really difficult". On her visit to a wellbeing garden at Colchester Hospital in Essex, England on Wednesday, she told the patients, "You put on a sort of brave face, stoicism through treatment, treatment’s done – then it’s like ‘I can crack on, get back to normal.’ But actually the phase afterwards is really difficult, you’re not necessarily under the clinical team any longer, but you’re not able to function normally at home as you perhaps once used to."

The reason she visited the hospital garden in the Southeast of England was to "celebrate the incredible healing power of nature", noted Kensington Palace.

She also met with patients and hospital staff at the Cancer Wellbeing Centre "to understand how gardens in healthcare setting play a crucial role in promoting good health outcomes, preventing poor health and supporting increased recovery time."

Now 43, Kate herself has pointed out to the importance of nature in her health journey over the last year.

Is There Any Scientific Proof That Nature Could Actually Heal You?

Lisa A Cooper, MD, MPH writes in the 'Letter from the Director' at John Hopkins Medicine that nature does have healing power. She notes that green spaces play a role in cardiovascular health, and also facilitates to interact with other people who are there to enjoy nature. The American Psychological Association (APA) also noted that spending time in nature is linked to both cognitive benefits and improvements in mood, mental health and emotional well-being. The University of Cincinnati also points out that being out in nature can further reduce anxiety, lower blood pressure, enhance immune system function, and boost self esteem and mood.

In fact in a video, which was posted by Kate on X to mark Mental Health Awareness Week in May, she said, "over the past year, nature has been my sanctuary."

Kate's Cancer Timeline

In March, Princess Kate publicly shared her cancer diagnosis and confirmed she had begun chemotherapy. As she focused on her recovery, she stepped away from the public eye, making only a few limited appearances over the summer. By September, she announced she had completed chemotherapy and was "doing what I can to stay cancer-free."

Since then, the Princess of Wales has been gradually re-engaging with her royal responsibilities. While she has increased her public appearances this year, palace insiders say she is carefully managing her return to balance her health with her official duties.

Earlier this summer, Kate made high-profile appearances at key royal events, including the Trooping the Colour parade in London and the Order of the Garter service in Windsor. However, she later withdrew from the Royal Ascot at the last minute, signaling that her return to full-time royal duties is still being handled with care.

Just last week, Kate resumed in-person engagements, joining Prince William in hosting philanthropist Melinda French Gates at Windsor Castle. The meeting, reportedly focused on their shared philanthropic interests, marked one of her first official engagements in recent weeks.

On Wednesday, the Princess made a meaningful visit to Colchester Hospital, where she helped plant several “Catherine’s Rose” plants—a specially bred rose named in her honor by the Royal Horticultural Society. The visit coincided with the hospital receiving a donation of 50 such plants.

The rose holds special significance: proceeds from its commercial sale will go to The Royal Marsden Cancer Charity, supporting cancer patients through treatment and beyond. The funds will help the charity develop a dedicated program focused on improving quality of life for those living with cancer and those who have completed treatment.

Princess Kate has deepened her connection with the Royal Marsden since her diagnosis. In January, Kensington Palace announced she had been named joint patron of The Royal Marsden NHS Foundation Trust, the specialist cancer center in Chelsea, west London, where she received treatment.

Her involvement with the charity and efforts to raise awareness reflect her commitment to supporting others navigating a cancer diagnosis. While her return to public life is cautious and measured, each appearance signals both her resilience and her intention to use her platform for meaningful causes.

As she continues to recover and adjust, the Princess of Wales remains one of the most admired and closely followed members of the royal family—balancing personal healing with her public role.